Shenzhen YHLO Biotech CoSHSE:688575 -3.03%64 FCF Yield % is 1.85 as of Jul. 07, 2026, which is 1956% above its 10-year median of 0.09. GuruFocus rates SHSE:688575 with a GF Score™ of 64/100 and a GF Value™ of ¥14.51 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks better than 64.25% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Shenzhen YHLO Biotech Co's FCF Yield % or its related term are showing as below:
SHSE:688575'
s FCF Yield % Range Over the Past 10 Years
Min: -6 Med: 0.09 Max: 9.54
Current: 1.85
During the past 9 years, the highest FCF Yield % of Shenzhen YHLO Biotech Co was 9.54%. The lowest was -6.00%. And the median was 0.09%.
SHSE:688575's FCF Yield % is ranked better than 64.25% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: -0.39
vs SHSE:688575: 1.85
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shenzhen YHLO Biotech Co FCF Yield % Related Terms
Shenzhen YHLO Biotech Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688575 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen YHLO Biotech Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Shenzhen YHLO Biotech Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen YHLO Biotech Co (SHSE:688575) has a FCF Yield % of 1.85 as of Jul. 07, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Shenzhen YHLO Biotech Co and its competitors. This is 1956% above median its historical median of 0.09. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #306 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 35.7%.
Is Shenzhen YHLO Biotech Co's FCF Yield % too high?
Shenzhen YHLO Biotech Co's current FCF Yield % of 1.85 is 1956% above median its 10-year median of 0.09. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #306 out of 856 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #306 out of 856 companies for FCF Yield %. This puts Shenzhen YHLO Biotech Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Shenzhen YHLO Biotech Co and its competitors. Shenzhen YHLO Biotech Co's current FCF Yield % is 1.85, which is 1956% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.51, compared to a current price of ¥8.97 — trading 38.2% below its estimated fair value. The current FCF Yield % is 1.85, which is 1956% above median its 10-year median of 0.09. Shenzhen YHLO Biotech Co's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current FCF Yield % is 1.85 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued.
The current stock price of ¥8.97 is trading 38.2% below its estimated GF Value™ of ¥14.51.
GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688575:
FCF Yield %: 1.85 (1956% above median its 10-year median of 0.09)
GF Value™: ¥14.51 vs. price of ¥8.97 (38.2% below fair value)
No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
64GF Score
Get the complete analysis for SHSE:688575
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688575 has been successfully added to your 
